Sudarshan Pharma Industries Ltd — Quarterly Results & Earnings

₹24.24

+5.48%

Profit Growth YoY-38.07%Latest quarter

Sales Growth YoY31.33%Latest quarter

Sales CAGR 5Y27.83%5 year compound

Profit CAGR 5Y69.73%5 year compound

📋

Quarterly Performance

YoY Profit Growth-38.07%

🔴 Significant decline

YoY Sales Growth+31.33%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

4.84%

EPS Growth 5Y

41.08%

Interest Coverage

Higher = safer debt servicing

2.23

ROE

14.83%

ROCE

15.51%

💡

Growth Analysis

Sudarshan Pharma Industries Ltd reported YoY profit growth of -38.07% and revenue growth of 31.33% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 27.83% and profits at 69.73% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Sudarshan Pharma Industries Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.